Last Update Time:
05-Feb-2025 09:31:15
ISIN:
INE123W01016
Sector:
Financial Services
Symbol:
SBILIFE
SBI Life Insurance Company Limited
₹1,470.35
₹-2.05
(-0.14%)
▼
Prev. Close
₹1,472.40
Open
₹1,472.40
Close
₹0.00
Range
₹1,396.83 - ₹1,543.87
High
₹1,483.25
Low
₹1,466.65
Ind. Close
₹0.00
VWAP
₹1,471.35
The current stock price of SBI Life Insurance Company Limited is ₹1,470.35, with a target price range between ₹1,396.83 and ₹1,543.87. The stock has experienced a price change of ₹-2.05 (-0.14%), reflecting recent market volatility.
Today's opening price was ₹1,472.40, while the previous close stood at ₹1,472.40. The intraday high reached ₹1,483.25, and the low touched ₹1,466.65. The volume-weighted average price (VWAP) is currently ₹1,471.35, indicating the stock's average traded price.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
SBI Life Insurance Company Limited Price Chart
SBI Life Insurance Company Limited Pre Open Market Overview: 05-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1472.4
- Previous Close Price: 1472.4
- Change: 0.00%
- Total Traded Volume: 203
- Total Buy Quantity: 9,500
- Total Sell Quantity: 6,237
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,466.50 | 10.00 | 0.00 |
| 1,468.00 | 6.00 | 0.00 |
| 1,470.00 | 38.00 | 0.00 |
| 1,471.95 | 33.00 | 0.00 |
| 1,472.00 | 18.00 | 0.00 |
| 1,472.40 | 0.00 | 223.00 |
| 1,472.95 | 0.00 | 6.00 |
| 1,474.00 | 0.00 | 1.00 |
| 1,476.80 | 0.00 | 10.00 |
| 1,476.95 | 0.00 | 9.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 1,470.00 | 359 | 1,470.35 | 4 |
| 1,469.75 | 18 | 1,470.45 | 6 |
| 1,469.70 | 1 | 1,470.55 | 771 |
| 1,469.65 | 10 | 1,470.60 | 1 |
| 1,469.60 | 38 | 1,470.65 | 1 |
Total Buy Quantity: 85,427
Total Sell Quantity: 77,728
Shareholding Patterns (in %) of SBI Life Insurance Company Limited
| Category | 31-Dec-2023 | 31-Mar-2024 | 30-Jun-2024 | 30-Sep-2024 | 31-Dec-2024 |
|---|---|---|---|---|---|
| Promoter & Promoter Group | 55.43 | 55.42 | 55.41 | 55.39 | 55.38 |
| Public | 44.57 | 44.58 | 44.59 | 44.61 | 44.62 |
| Shares held by Employee Trusts | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics of SBI Life Insurance Company Limited
The trade information for SBI Life Insurance Company Limited includes a total traded volume of 0.32 lakh shares, and a traded value of ₹4.69 crore.
The market cap is ₹147,342.16 crore, with a free float market cap of ₹65,633.24 crore. The deliverable quantity is 376,672.00 shares, reflecting 61.26% of total trades.
Key risk indicators include security VaR at 9.44% and an applicable margin rate of 12.94%.
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.32 |
| Traded Value (₹ Cr.) | 4.69 |
| Total Market Cap (₹ Cr.) | 147,342.16 |
| Free Float Market Cap (₹ Cr.) | 65,633.24 |
| Impact cost | 0.04 |
| Quantity Traded | 614,905.00 |
| Deliverable Quantity | 376,672.00 |
| % of Quantity to Traded | 61.26 |
| Security VaR | 9.44 |
| Index VaR | N/A |
| VaR Margin | 9.44 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 12.94 |
| Face Value | 10 |
Key Price Statistics of SBI Life Insurance Company Limited
The 52-week high for SBI Life Insurance Company Limited was ₹1,936.00, recorded on 03-Sep-2024. On the other hand, the 52-week low stands at ₹1,307.70, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹N/A, and the lower band is ₹N/A. The price band is No Band%.
The stock's daily volatility stands at 1.50, while the annualized volatility is 28.66. The tick size for trading is ₹N/A.
| Price Information | Details |
|---|---|
| 52 Week High (03-Sep-2024) | 1,936.00 |
| 52 Week Low (04-Jun-2024) | 1,307.70 |
| Upper Band | 1,619.60 |
| Lower Band | 1,325.20 |
| Price Band (%) | No Band |
| Daily Volatility | 1.50 |
| Annualised Volatility | 28.66 |
| Tick Size | 0.05 |
Key Securities Statistics of SBI Life Insurance Company Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 03-Oct-2017 |
| Adjusted P/E | 61.21 |
| Symbol P/E | 61.21 |
| Index | NIFTY 50 |
| Macro-Economic Sector | Financial Services |
| Sector | Financial Services |
| Industry | Insurance |
| Basic Industry | Life Insurance |
Security Status of SBI Life Insurance Company Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of SBI Life Insurance Company Limited
| Subject | Date |
|---|---|
| General Updates | 03-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 24-Jan-2025 |
| Integrated Filing- Financial | 17-Jan-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 17-Jan-2025 |
| Press Release (Revised) | 17-Jan-2025 |
| Press Release | 17-Jan-2025 |
| Outcome of Board Meeting | 17-Jan-2025 |
| Financial Result Updates | 17-Jan-2025 |
Corporate Actions of SBI Life Insurance Company Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Interim Dividend - Rs 2.70 Per Share | 15-Mar-2024 |
| 10 | Interim Dividend - Rs 2.50 Per Share | 16-Mar-2023 |
| 10 | Interim Dividend - Rs 2 Per Share | 29-Mar-2022 |
| 10 | Interim Dividend - Rs 2.5 Per Share | 05-Apr-2021 |
| 10 | Interim Dividend - Rs 2 Per Share | 03-Apr-2019 |
| 10 | Interim Dividend - Rs 2 Per Share (Purpose Revised) | 03-Apr-2018 |
Board Meetings of SBI Life Insurance Company Limited
Financial Results of SBI Life Insurance Company Limited
| Qtr Ended | Tot. Income | Net P/L | EPS | Notes |
|---|---|---|---|---|
| 31 Dec 2024 | 1,854,216 | 55,082 | 5.49 | |
| 30 Sep 2024 | 4,001,504 | 52,942 | 5.28 | |
| 30 Jun 2024 | 3,439,205 | 51,953 | 5.18 |
Company Directory of SBI Life Insurance Company Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.sbilife.co.in | Registered Office | NATRAJ, M. V. Road and Western Express Highway Junction Andheri (East) | MUMBAI |
| www.sbilife.co.in | Transfer Agent | KFin Technologies Limited Selenium Tower B Plot 31-32, Gachibowli, Financial District, Nanakramguda, Serilingampally | HYDERABAD |
Insider Trading of SBI Life Insurance Company Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | BNP Paribas Cardif | 2204045827 | Sell |
| 7(2) | Mr. Debasis Chatterjee | 4999866 | Sell |
| 7(2) | Mr. Ashish Ranjan | 562450 | Buy |
| 7(2) | Mr. Ashish Ranjan | 908515 | Sell |
| 7(2) | K Ramkumar | 2368347 | Sell |
| 7(2) | V Ganesh | 1400000 | Sell |
| 7(2) | Mr. Harikrish V | 1012410 | Buy |
| 7(2) | Mr. Ramkumar Krishnamoorthy | 1321196 | Buy |
| 7(2) | Mr. Debasis Chatterjee | 2812250 | Buy |
| 7(2) | Mr. Anurag Misra | 1383627 | Buy |
| 7(2) | Mr. Ravi Krishnamurthy | 4025790 | Buy |
| 7(2) | Mr. Ravindra Kumar | 2397725 | Buy |
| 7(2) | Mr. Abhijit Gulanikar | 15361855 | Sell |
| 7(2) | Mr. Ravi Krishnamurthy | 11327565 | Sell |
| 7(2) | Mr. Abhijit Gulanikar | 8865337 | Buy |
| 7(2) | Mr. Mohammed Rafik Botawala | 1027488 | Sell |
| 7(2) | Mr. Ravi Krishnamurthy | 6580665 | Buy |
| 7(2) | Mr. Abhijit Gulanikar | 1110505 | Sell |
| 7(2) | Mr. Madhukar Nath | 1012410 | Buy |
| 7(2) | BNP Paribas Cardif S.A. | 45567106250 | Sell |
Annual Reports of SBI Life Insurance Company Limited
Investor Complaints of SBI Life Insurance Company Limited
| Date | Pending | Received | Disposed | Unresolved |
|---|---|---|---|---|
| 31-Dec-2024 | 5 | 4 | 9 | 0 |
| 30-Sep-2024 | 0 | 24 | 19 | 5 |
| 30-Jun-2024 | 0 | 7 | 7 | 0 |
| 31-Mar-2024 | 0 | 12 | 12 | 0 |
| 31-Dec-2023 | 1 | 1 | 2 | 0 |
| 30-Sep-2023 | 0 | 3 | 2 | 1 |
| 30-Jun-2023 | 0 | 15 | 15 | 0 |
| 31-Mar-2023 | 0 | 17 | 17 | 0 |
| 31-Dec-2022 | 3 | 18 | 21 | 0 |
| 30-Sep-2022 | 1 | 38 | 36 | 3 |
| 30-Jun-2022 | 0 | 43 | 42 | 1 |
| 31-Mar-2022 | 0 | 10 | 10 | 0 |
| 31-Dec-2021 | 0 | 16 | 16 | 0 |
| 30-Sep-2021 | 0 | 20 | 20 | 0 |
| 30-Jun-2021 | 0 | 31 | 31 | 0 |
| 31-Mar-2021 | 0 | 6 | 6 | 0 |
| 31-Dec-2020 | 0 | 12 | 12 | 0 |
| 30-Sep-2020 | 0 | 18 | 18 | 0 |
| 30-Jun-2020 | 0 | 4 | 4 | 0 |
| 31-Mar-2020 | 0 | 12 | 12 | 0 |
| 31-Dec-2019 | 0 | 32 | 32 | 0 |
| 30-Sep-2019 | 0 | 74 | 74 | 0 |
| 30-Jun-2019 | 0 | 31 | 31 | 0 |
| 31-Mar-2019 | 0 | 10 | 10 | 0 |
| 31-Dec-2018 | 0 | 24 | 24 | 0 |
| 30-Sep-2018 | 0 | 76 | 76 | 0 |
| 30-Jun-2018 | 0 | 82 | 82 | 0 |
| 31-Mar-2018 | 1 | 15 | 16 | 0 |
| 31-Dec-2015 | 0 | 226 | 225 | 1 |
Event Calendar of SBI Life Insurance Company Limited
| Purpose | Details |
|---|---|
| Results | To consider and approve the audited accounts for the quarter and half year ended September 30, 2017. |
| Results | to consider the unaudited accounts for the quarter ended December 31, 2017. |
| Dividend | To consider Interim dividend for Financial Year 2017-18 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the half year ended September 30, 2018 |
| Financial Results | Board Meeting Intimation for the Quarter And Nine Months Ended December 31, 2018 |
| Dividend | To consider and approve payment of interim dividend for the Financial Year 2018-19, if any. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Dividend | To consider dividend |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Dividend | SBI Life Insurance Company Limited has informed the Exchange about Board Meeting to be held on 22-Mar-2022 to consider Dividend |
| Financial results | SBI Life Insurance Company Limited has informed the Exchange about Board Meeting to be held on 28-Apr-2022 to consider financial statements for the period ended March 2022 |
| Financial results | We wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, July 28, 2022 to consider and approve unaudited financial results for the quarter ended June 30, 2022.The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations.Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and in continuation to our letter dated June 30, 2022 bearing reference number SBIL/F&A-CS/NSE-BSE/2223/89 the trading window will remain closed from July 01, 2022 to July 30, 2022 (both days inclusive) for declaration of unaudited financial results for the quarter ended June 30, 2022. |
| Financial results | SBI Life Insurance Company Limited has informed the Exchange about Board Meeting to be held on 21-Oct-2022 to consider financial statements for the period ended September 2022Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and in continuation to our letter dated September 30, 2022 bearing reference number SBIL/F&A-CS/NSE-BSE/2223/215 the trading window will remain closed from October 01, 2022 to October 23, 2022 (both days inclusive) for declaration of financial results for the quarter and half year ended September 30, 2022. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Dividend | To consider and declare payment of Interim Dividend on equity shares of the Company for the Financial Year 2022-23 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Dividend | To consider dividend |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of SBI Life Insurance Company Limited
Voting Results of SBI Life Insurance Company Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 26-AUG-2024 | AGM | To receive, consider and adopt the Revenue Account, Profit and Loss Account and Receipts and Payments Account for the financial year ended March 31, 2024 and the Balance Sheet of the Company as at March 31, 2024, together with the reports of the Board of Directors of the Company (￢ﾀﾜBoard￢ﾀﾝ), report of the Statutory Auditors of the Company (￢ﾀﾜAuditors￢ﾀﾝ) and comments of the Comptroller and Auditor General of India (￢ﾀﾜCAG￢ﾀﾝ). |
| 26-AUG-2024 | AGM | Revision in the remuneration of Mr. Amit Jhingran (DIN: 10255903), Managing Director & Chief Executive Officer (￢ﾀﾜCEO￢ﾀﾝ) of the Company |
| 26-AUG-2024 | AGM | Continuation of Mr. Dinesh Kumar Khara (DIN: 06737041), as chairman, Nominee Director of the Company |
| 26-AUG-2024 | AGM | Fixation of remuneration of the Statutory Auditors of the Company in accordance with the section 142 of the Companies Act, 2013, as yet to be appointed by the Comptroller and Auditor General of India, for the financial year 2024-25 in furtherance of its powers embodied within Section 139 of Companies Act, 2013, as amended and read with applicable notifications issued thereunder. |
| 26-AUG-2024 | AGM | To confirm the interim dividend declared by the Company on March 10, 2024 as final dividend for the year ended March 31, 2024. |
| 23-AUG-2024 | Postal Ballot | Approval for re-appointment of Ms. Usha Sangwan (DIN: 02609263), as an Independent Director of the Company |
| 30-MAR-2024 | Postal Ballot | To approve appointment of Mr. Ashwini Kumar Tewari (DIN: 08797991), as the Nominee Director of the Company |
| 30-MAR-2024 | Postal Ballot | Approval for entering into Material Related Party Transaction with State Bank of India |
| 30-MAR-2024 | Postal Ballot | Approval for entering into Material Related Party Transaction for purchase and / or sale of investments |
| 29-NOV-2023 | Postal Ballot | To approve appointment of Mr. Amit Jhingran (DIN:10255903) as the Managing Director & CEO of the Company |
| 29-AUG-2023 | AGM | To receive, consider and adopt the Revenue Account, Profit and Loss Account and Receipts and Payments Account for the financial year ended March 31, 2023 and the Balance Sheet of the Company as at March 31, 2023, together with the reports of the Board of Directors of the Company (￢ﾀﾜBoard￢ﾀﾝ), report of the Statutory Auditors of the Company (￢ﾀﾜAuditors￢ﾀﾝ) and comments of the Comptroller and Auditor General of India (￢ﾀﾜCAG￢ﾀﾝ). |
| 29-AUG-2023 | AGM | Re-appointment of Dr. Tejendra M. Bhasin (DIN: 03091429), as an Independent Director of the Company |
| 29-AUG-2023 | AGM | Re-appointment of Mr. Shobinder Duggal (DIN: 00039580), as an Independent Director of the Company |
| 29-AUG-2023 | AGM | Re-appointment of Mr. Narayan K. Seshadri (DIN:00053563), as an Independent Director of the Company |
| 29-AUG-2023 | AGM | For fixation of Remuneration of Joint Statutory Auditor as yet to be appointed by the Comptroller and Auditor General of India, for the FY 2023-24 |
| 29-AUG-2023 | AGM | To confirm the interim dividend declared by the Company on March 08, 2023 as final dividend for the year ended March 31, 2023. |
| 29-JUL-2023 | Postal Ballot | To approve re-appointment of Mr. Mahesh Kumar Sharma (DIN:08740737), as a Managing Director & CEO of the Company |
| 29-AUG-2022 | AGM | To receive, consider and adopt the Revenue Account, Profit and Loss Account and Receipts and Payments Account for the financial year ended March 31, 2022 and the Balance Sheet of the Company as at March 31, 2022, together with the reports of the Board of Directors of the Company (￢ﾀﾜBoard ), report of the Statutory Auditors of the Company (￢ﾀﾜAuditors ) and comments of the Comptroller and Auditor General of India (￢ﾀﾜCAG ). |
| 29-AUG-2022 | AGM | For fixation of remuneration of the Joint Statutory Auditors as yet to be appointed by Comptroller and Auditor General of India for the FY 2022-23. |
| 29-AUG-2022 | AGM | To confirm the interim dividend declared by the Company on March 22, 2022 as final dividend for the year ended March 31, 2022. |